BENF vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits severe financial distress with a Piotroski F-Score of just 1/9, indicating very weak fundamental health. Negative profitability metrics, including a Price/Book of -0.02 and ROE of -551.08%, reflect deep structural issues. Despite a bullish analyst target price of $16.00, the stock's operational instability, extreme earnings volatility, and lack of reliable financial data undermine any valuation confidence. The technical trend is bearish, and recent price swings suggest speculative trading rather than fundamental recovery.
BRK-B shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
BENF vs BRK-B: Head-to-Head Comparison
This page compares Beneficient (BENF) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.